Cancer Screening for Transgender Individuals: Guidelines, Best Practices, and a Proposed Care Model

Urol Clin North Am. 2023 Nov;50(4):563-576. doi: 10.1016/j.ucl.2023.06.014. Epub 2023 Aug 12.

Abstract

Few transgender-specific cancer screening recommendations exist. This review aims to cover current guidelines and practice patterns of cancer screening in transgender patients and, where evidence-based data are lacking, to draw from cisgender screening guidelines to suggest best practices for transgender patients based on anatomic inventory. Sufficient evidence does not exist to determine the long-term effects of gender-affirming hormone therapy on cancer risk. In the future, cancer screening and prevention should be focused on anatomic inventory and high-risk behaviors.

Keywords: Cancer screening; Gender-affirming hormone therapy; Gender-affirming surgery; Trans female; Trans male; Transgender health.

Publication types

  • Review

MeSH terms

  • Early Detection of Cancer
  • Humans
  • Neoplasms* / diagnosis
  • Neoplasms* / prevention & control
  • Risk
  • Transgender Persons*
  • Transsexualism*